Back to Trades
Doux John
DirectorCIK 0001912574
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Doux John, Director, has filed 3 SEC reports (2026), all concentrated in PALVELLA THERAPEUTICS, INC. (PVLA), totaling $1.1M in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.